Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology
- PMID: 20686167
- PMCID: PMC3036969
- DOI: 10.4049/jimmunol.1000108
Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology
Abstract
Recent studies have reported that adenosine is a significant mediator of regulatory T cell (Treg) function. Indeed, activation of the adenosine receptor subtypes expressed by a broad range of immune and inflammatory cells attenuates inflammation in several disease models. This anti-inflammatory response is associated with an increase in intracellular cAMP that inhibits cytokine responses of many immune/inflammatory cells, including T cells and APCs. Thus, adenosine produced by Tregs can provide a paracrine feedback that shapes the host response following an immunologic provocation. This review discusses the evidence that adenosine is an integral part of Treg biology and presents some of the mechanisms that may account for its contribution to the resolution of inflammation and the regulation of the immune/inflammatory cell phenotype.
Figures



Similar articles
-
Immunological alterations mediated by adenosine during host-microbial interactions.Immunol Res. 2011 May;50(1):69-77. doi: 10.1007/s12026-011-8207-0. Immunol Res. 2011. PMID: 21479929 Free PMC article. Review.
-
[Immune regulation via the generation of extracellular adenosine by CD73].Seikagaku. 2014 Dec;86(6):766-9. Seikagaku. 2014. PMID: 25675814 Review. Japanese. No abstract available.
-
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.Nat Rev Nephrol. 2020 Sep;16(9):509-524. doi: 10.1038/s41581-020-0304-7. Epub 2020 Jul 8. Nat Rev Nephrol. 2020. PMID: 32641760 Review.
-
Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells.Mol Immunol. 2010 Jan;47(4):678-84. doi: 10.1016/j.molimm.2009.10.032. Epub 2009 Nov 24. Mol Immunol. 2010. PMID: 19939455
-
Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8(+) T-cell priming capacity.Immunology. 2013 Apr;138(4):402-10. doi: 10.1111/imm.12053. Immunology. 2013. PMID: 23278551 Free PMC article.
Cited by
-
Regulation of inflammation by adenosine.Front Immunol. 2013 Apr 8;4:85. doi: 10.3389/fimmu.2013.00085. eCollection 2013. Front Immunol. 2013. PMID: 23580000 Free PMC article.
-
Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose-6-phosphate isomerase peptide-induced arthritis.Immun Inflamm Dis. 2016 Jun 8;4(3):263-73. doi: 10.1002/iid3.111. eCollection 2016 Sep. Immun Inflamm Dis. 2016. PMID: 27621810 Free PMC article.
-
scRNA-seq profiling of neonatal and adult thymus-derived CD4+ T cells by a T cell origin-time tracing model.J Mol Cell Biol. 2023 Apr 20;14(12):mjac072. doi: 10.1093/jmcb/mjac072. J Mol Cell Biol. 2023. PMID: 36542462 Free PMC article.
-
CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.Transpl Immunol. 2015 Mar;32(2):76-83. doi: 10.1016/j.trim.2015.01.003. Epub 2015 Feb 7. Transpl Immunol. 2015. PMID: 25661084 Free PMC article.
-
Immunological alterations mediated by adenosine during host-microbial interactions.Immunol Res. 2011 May;50(1):69-77. doi: 10.1007/s12026-011-8207-0. Immunol Res. 2011. PMID: 21479929 Free PMC article. Review.
References
-
- Lukashev DE, Smith PT, Caldwell CC, Ohta A, Apasov SG, Sitkovsky MV. Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs. Biochem. Pharmacol. 2003;65:2081–2090. - PubMed
-
- Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 2004;22:657–682. - PubMed
-
- Wakamiya M, Blackburn MR, Jurecic R, McArthur MJ, Geske RS, Cartwright J, Jr., Mitani K, Vaishnav S, Belmont JW, Kellems RE, et al. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. USA. 1995;92:3673–3677. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous